High PRMT5 levels, maintained by KEAP1 inhibition, drive chemoresistance in high-grade serous ovarian cancer is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: U54CA268084
National Institutes of Health
Grant: R01CA267544
National Institutes of Health
Grant: 4R01CA267544-04
Chemo-mediated transcriptional reprogramming in ovarian cancer
National Institutes of Health
Grant: 1U54CA268084-01
Northwestern University Center for Chromatin NanoImaging in Cancer (NU-CCNIC)
Fields of Study
Keywords